Daré Bioscience, Inc.DARENASDAQ
Loading
Year-over-year debt growth rate
Latest
-3.30%
↓ 109% vs avg
Percentile
P59
Within normal range
Streak
1 qtr
Consecutive growthRecovering
Average
38.55%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | -3.30% |
| Q2 2025 | -63.52% |
| Q1 2025 | 538.05% |
| Q4 2024 | -77.89% |
| Q3 2024 | 286.49% |
| Q2 2024 | -7.13% |
| Q1 2024 | 16.91% |
| Q4 2023 | 621.77% |
| Q3 2023 | -34.07% |
| Q2 2023 | -24.88% |
| Q1 2023 | -19.61% |
| Q4 2022 | -16.13% |
| Q3 2022 | -49.24% |
| Q2 2022 | -4.94% |
| Q1 2022 | 346.35% |
| Q4 2021 | -29.51% |
| Q3 2021 | -22.06% |
| Q2 2021 | -17.40% |
| Q1 2021 | -21.22% |
| Q4 2020 | -11.98% |
| Q3 2020 | -10.38% |
| Q2 2020 | 39.34% |
| Q1 2020 | -13.97% |
| Q4 2019 | 190.61% |
| Q3 2019 | 137.26% |
| Q2 2019 | -16.66% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | -100.00% |
| Q2 2017 | 6.90% |
| Q1 2017 | -93.78% |
| Q4 2016 | -13.03% |
| Q3 2016 | -11.54% |
| Q2 2016 | -10.01% |
| Q1 2016 | -8.88% |
| Q4 2015 | 39.58% |